Showing 1 - 6 results of 6 for search 'Lucy Chou', query time: 0.02s
Refine Results
-
1
Critical roles for ‘housekeeping’ nucleases in type III CRISPR-Cas immunity by Lucy Chou-Zheng, Asma Hatoum-Aslan
Published 2022-12-01
Article -
2
A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity by Lucy Chou-Zheng, Asma Hatoum-Aslan
Published 2019-04-01
Article -
3
Case report: Severe asymptomatic hypertriglyceridemia associated with long-term low-dose rapamycin administration in a healthy middle-aged Labrador retriever by Jeremy B. Evans, Lucy Chou, Matt Kaeberlein, Matt Kaeberlein, Daniel E.L. Promislow, Daniel E.L. Promislow, Kate E. Creevy
Published 2023-11-01
Article -
4
The structure of a Type III-A CRISPR-Cas effector complex reveals conserved and idiosyncratic contacts to target RNA and crRNA among Type III-A systems. by Mohammadreza Paraan, Mohamed Nasef, Lucy Chou-Zheng, Sarah A Khweis, Allyn J Schoeffler, Asma Hatoum-Aslan, Scott M Stagg, Jack A Dunkle
Published 2023-01-01
Article -
5
A masked, placebo-controlled, randomized clinical trial evaluating safety and the effect on cardiac function of low-dose rapamycin in 17 healthy client-owned dogs by Brian G. Barnett, Sonya R. Wesselowski, Sonya G. Gordon, Ashley B. Saunders, Daniel E. L. Promislow, Daniel E. L. Promislow, Stephen M. Schwartz, Lucy Chou, Jeremy B. Evans, Matt Kaeberlein, Kate E. Creevy
Published 2023-05-01
Article -
6
Development and evaluation of a survey instrument to assess veterinary medical record suitability for multi-center research studies by Dora Praczko, Amanda K. Tinkle, Crystal R. Arkenberg, Robyn L. McClelland, Kate E. Creevy, M. Katherine Tolbert, Brian G. Barnett, Lucy Chou, Jeremy Evans, Kellyn E. McNulty, Dog Aging Project Consortium, Jonathan M. Levine
Published 2022-08-01
Article